1.Global Initiative For Asthma. (2017). Global Strategy for Asthma Management and Prevention. [online] Available at:https://ginasthma.org/wp-content/uploads/2018/04/wms-GINA-2018-report-tracked_v1.3.pdf[Accessed 15th February 2019].
2.Enrico H, Lorena N, Girardi M, Matteo F, Francesca P, Luca M , Gianni P, Giorgio. Inhaled Corticosteroids Safety and Adverse Effects in Patients with Asthma .The Journal of Allergy and Clinical Immunology in Practice .2008;6-3:776-781
3. Nicola A, Kenneth R C, William CS, John P S,Steven K ,Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. Journal of allergy and clinical immunology.2005;571-579
4.Issa EK Karine. CSACI position statement: systemic effect of inhaled corticosteroids on adrenal suppression in the management of pediatric asthma.Allergy, asthma, and clinical immunology.2015;11:1- 9
5.Ronald D.Systemic side effects of inhaled corticosteroids in patients with asthma.Respiratory Medicine. 2006;100:1307-1317
6.Alexandra A, Harold K, Sheldon S. Adrenal suppression :A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy.Allergy, Asthma & Clinical Immunology. 2011; 7:13
7.Kurahashi I, Matsunuma A, Kawane T, Abe M, Horiuchi N. Deaxamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR-106) and renal (LLC-PK1) cells treated with 1α,25-dihyroxyvitamin D3. Endocrine. 2002;17:109-118
8.Dhawan P, Christakos S, Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)ase transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBPβ, and the vitamin D receptor in 24(OH) ase transcription. J Cell Biochem. 2010; 110: 1314-1323
9.Tanner JM, Goldstein H, Whitehouse RH. Standards for children’s height at ages 2-9 years allowing for height of parents. Archives of Disease in Childhood .1970;45:755-62
10.Park J, Mohammed D, Joanne B.The diagnosis and treatment of adrenal insufficiency during childhood and adolescence . Arch Dis Child,2016;101:860–865.
11.Craig F, Munns N, Bonny L. Global Consensus Recommendations on Prevention and Management of Nutritional Rickets. Horm Res Paediatr .2016;85:83-106.
12.Allen DB. Sense and sensitivity: assessing inhaled corticosteroid effects on the hypothalamic- pituitary-adrenal axis. Ann Allergy Asthma Immunology. 2002; 89:537-9.
13.Santiago AH, Ratzan S.Acute adrenal crisis in an asthmatic child treated with inhaled fluticasone proprionate. Int J Pediatr Endocrinol.2010:749239. doi:10.1155/2010/749239
14 Drake AJ, Howells RJ, Shield JPH, Prendiville A, Ward PS, Crowne EC . Symptomatic adrenal insufficiency presenting with hypoglycaemia in asthmatic children with asthma receiving high dose inhaled fluticasone propionate.British Medical Journal. 2002;324(7345):1081–1082.
15.Kannisto S, Korppi M, Remes K, Voutilainen R.Adrenal suppression, evaluated by a low dose adrenocorticotropin test, and growth in asthmatic children treated with inhaled steroids. J Clin Endocrinol Metab.2000;85(2):652-7
16.Zollner EW, Lombard CJ, Galal U, Hough S, Irusen EM, Weinberg E, Hypothalamic-pituitary-adrenal axis suppression in asthmatic school children. Pediatrics,2012;130:e1512.
17.Agertoft L, Pedersen S. Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. New England Journel Medicine.2000; 343:1064–1069.
18.Soren Pedersen. Do Inhaled Corticosteroids Inhibit Growth in Children? American Journal of Respiratory and Critical Care Medicine.164(4):521–535
19 EfthimiouJ,Barnes PJ. Effect of inhaled corticosteroids on bones and growth. European Respiratory Journal.1998;11: 1167-1177
20.Pruteanu AI, Chauhan BF, Zhang L, Prietsch SO, Ducharme FM. Inhaled corticosteroids in children with persistent asthma: effects on growth.Cochrane Database Systemic Review.2014; (7)doi: 10.1002/14651858.
21.Thomas BC , Stanhope R, Grant DB.Impaired growth in children with asthma during treatment with conventional doses of inhaled corticosteroids.1994; Acta Paediatr 83(2):196-9.
22.Wright CM, Cheetham CD.The strengths and limitations of parental heights as a predictor of attained height. Archives of Disease in Childhood.1999; 81(3):257-60
23.Axelsson I, Naumburg E, Prietsch SOM, Zhang L. Inhaled corticosteroids in children with persistent asthma: effects of different drugs and delivery devices on growth. Cochrane Database of Systematic Reviews 2019, Issue 6. Art. No.: CD010126.
24.Fatma D, Ozlem KARA, Derya TEPE, Ihsan ESEN.Bone Mineral density and vitamin D status in children and adolescents with congenital adrenal hyperplasi Turkish journal of Medical Sciences.2014;109-114
25.Tse SM, Kelly HW, Litonjua AA, Van Natta ML, Weiss ST, Tantisira KG. Corticosteroid use and bone mineral accretion in children with asthma: effect modification by vitamin D. Journal of Allergy Clinical Immunology.2012; 53-60
26.Arend EE, Fischer GB, Debiasi M, Schmid H Inhaled corticosteroid treatment and growth of asthmatic children seen at outpatient clinics. J Pediatr (Rio J).2006;82(3):197-203.
27.David P. Skoner. Inhaled corticosteroids Effects on growth and bone health. Alergy Asthma Immunology.2016; 117 ,595
28.Allen HD, Thong IG, Clifton-Bligh P, Holmes S, Nery L, Wilson KB. Effects ofhigh-dose inhaled corticosteroids on bone metabolism in prepubertal childrenwith asthma. PediatrPulmonol.2000;29:188e193
29.Hopp RJ, Degan JA, Phelan J, Lappe J, Gallagher GC. Cross-sectional study of bone density in asthmatic children. PediatrPulmonol.1995; 20:189e192.
30.The Childhood Asthma Management Program Research Group.Long-termeffects of budesonide or nedocromil in children with asthma. N Engl J Med.2000; 343:1054-1063
31.Della Giustina A, Landi M, Bellini F, et al. Vitamin D, allergies and asthma: focus on pediatric patients. World Allergy Organ J. 2014;7(1):27.